The White House has withdrawn its nomination of Heidi Overton to lead the Food and Drug Administration (FDA), a White House official confirmed to the Guardian. Donald Trump had nominated Overton, a physician and prominent abortion opponent, in August.
Overton's nomination was intended to bring a Trump loyalist to the agency. However, she faced bipartisan scrutiny in the Senate, particularly concerning her willingness to diverge from Trump's claims about childhood vaccines.
Republican Senator Bill Cassidy, who chairs the Senate health committee, had expressed being undecided on her nomination and previously called her support for Trump's plan to separate combination vaccines "almost disqualifying." The withdrawal occurred a day before a key Senate health, labor and pensions committee vote was scheduled.
As head of the FDA, Overton would have overseen the regulation of medication abortions. In a 2023 policy brief, she advocated for strict regulation of the abortion pill mifeprestone and criticised federal policies allowing the mailing of abortion pills.